Trump Outlines Plan for Fourth Cycle of Medicare Drug Price Cuts

The Trump administration released Friday a proposed plan for how it will tackle the fourth cycle of Medicare’s drug price negotiation program.

The proposed rule (RIN 0938-AV90), issued by the Centers for Medicare & Medicaid Services, lays the groundwork for how the US government will select and slash the prices of 20 prescription drugs covered under Medicare Part B and Part D. Those prices are slated to go into effect in 2029.

“We are moving from annual updates to a permanent, predictable framework,” CMS Administrator Mehmet Oz said in a statement. “This approach puts patients first, strengthens Medicare, ...